Drugs Made In America Acquisition Corp. (DMAA)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
10. 87
0
0%
$
263.89M Market Cap
- P/E Ratio
- Div Yield
800 Volume
- Eps
$ 10.87
Previous Close Want to track DMAA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Drugs Made In America Acquisition Corp. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Daniel L. Lippincott Karpus Management Inc. | 2.51M | $25.2M | $27.26M | $2.06M | 8.16% |
| DB David Barlow Glazer Capital LLC | 1.68M | $16.82M | $18.24M | $1.43M | 8.48% |
| BO Brian Oliveira Clear Street Group Inc. | 382,440 | $3.96M | $4.16M | $201,706.24 | 5.1% |
2026 © Marketlog. All Rights Reserved.
